Literature DB >> 23917522

Severity of mitral regurgitation predicts risk of death or cardiac transplantation in children with idiopathic dilated cardiomyopathy.

Amit Patange1, Ronald Thomas, Robert D Ross.   

Abstract

Clinical outcomes among children with idiopathic dilated cardiomyopathy (IDC) are diverse, which makes the decision as to when a patient should be listed for a cardiac transplantation challenging. This study aimed to determine echocardiographic and clinical variables that can help clinicians identify those at highest risk for death or cardiac transplantation. The study was a single-center, retrospective chart review of children with IDC. Patients younger than 18 years with a diagnosis of IDC, as defined by a left ventricular end-diastolic dimension (LVEDD) z-score higher than 2, and fractional shortening of less than 28 % on the initial echocardiogram, were included in the study. Echocardiographic parameters including mitral regurgitation (MR) grade and certain clinical parameters at the time of presentation were assessed. A follow-up echocardiogram was similarly studied. The study included 49 children with IDC. Those who died or underwent cardiac transplantation were grouped as "nonsurvivors" (n = 26). The remaining children who either completely recovered or experienced chronic dilated cardiomyopathy were grouped as "survivors" (n = 23). The median age overall was 1.25 years (range 0.1-17 years). The follow-up echocardiograms of the survivors showed significant improvement in left ventricle size, systolic function, left atrial volume, and MR grade, whereas these parameters did not change in the nonsurvivor group. The use of inotropic medications at initial presentation was an independent predictor of death or cardiac transplantation (p < 0.05). The presence of moderate to severe MR at diagnosis also was predictive of a worse outcome.

Entities:  

Mesh:

Year:  2013        PMID: 23917522     DOI: 10.1007/s00246-013-0764-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  18 in total

1.  Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study.

Authors:  Piers E F Daubeney; Alan W Nugent; Patty Chondros; John B Carlin; Steven D Colan; Michael Cheung; Andrew M Davis; C W Chow; Robert G Weintraub
Journal:  Circulation       Date:  2006-11-20       Impact factor: 29.690

2.  Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.

Authors:  Michele De Bonis; Elisabetta Lapenna; Alessandro Verzini; Giovanni La Canna; Antonio Grimaldi; Lucia Torracca; Francesco Maisano; Ottavio Alfieri
Journal:  Ann Thorac Surg       Date:  2008-03       Impact factor: 4.330

3.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

4.  Outcome factors of idiopathic dilated cardiomyopathy in children - a long-term follow-up review.

Authors:  Vitor Manuel P Azevedo; Marco Aurelio Santos; Francisco M Albanesi Filho; Márcia B Castier; Bernardo R Tura; Jose Geraldo C Amino
Journal:  Cardiol Young       Date:  2007-01-23       Impact factor: 1.093

5.  Usefulness of mitral regurgitation as a marker of increased risk for death or cardiac transplantation in idiopathic dilated cardiomyopathy in children.

Authors:  Fernanda P Fernandes; Cedric Manlhiot; Brian W McCrindle; Luc Mertens; Paul F Kantor; Mark K Friedberg
Journal:  Am J Cardiol       Date:  2011-03-04       Impact factor: 2.778

6.  Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry.

Authors:  Susan R Foerster; Charles E Canter; Amy Cinar; Lynn A Sleeper; Steven A Webber; Elfriede Pahl; Paul F Kantor; Jorge A Alvarez; Steven D Colan; John L Jefferies; Jacqueline M Lamour; Renee Margossian; Jane E Messere; Paolo G Rusconi; Robert E Shaddy; Jeffrey A Towbin; James D Wilkinson; Steven E Lipshultz
Journal:  Circ Heart Fail       Date:  2010-09-10       Impact factor: 8.790

7.  Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history.

Authors:  C P Taliercio; J B Seward; D J Driscoll; L D Fisher; B J Gersh; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-11       Impact factor: 24.094

8.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.

Authors:  H J Why; B T Meany; P J Richardson; E G Olsen; N E Bowles; L Cunningham; C A Freeke; L C Archard
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

9.  Is myocardial performance index an independent echocardiographic marker of death in children with idiopathic dilated cardiomyopathy?

Authors:  Vitor Manuel P Azevedo; Francisco M Albanesi Filho; Marco Aurélio Santos; Márcia B Castier; Bernardo R Tura; José Geraldo Amino; Maria Ourinda Mesquita Da Cunha
Journal:  Clin Cardiol       Date:  2008-09       Impact factor: 2.882

10.  Three methods for evaluation of left atrial volume.

Authors:  Panupong Jiamsripong; Tadaaki Honda; Christina S Reuss; R Todd Hurst; Hari P Chaliki; Diane E Grill; Stephen L Schneck; Rochelle Tyler; Bijoy K Khandheria; Steven J Lester
Journal:  Eur J Echocardiogr       Date:  2007-07-23
View more
  1 in total

1.  Parameters affecting outcome of paediatric cardiomyopathies in the intensive care unit: experience of an Egyptian tertiary centre over 7 years.

Authors:  Alaa A Sobeih; Sonia A El-Saiedi; Noha S Abdel Khalek; Shereen A Attia; Baher M Hanna
Journal:  Libyan J Med       Date:  2020-12       Impact factor: 1.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.